By Cecilia Butini


Bayer AG said Tuesday that it has entered into a development-and-license agreement with U.K.-based company Blackford Analysis Ltd. to build a digital platform for medical imaging.

Under the agreement, Bayer will create artificial intelligence-enabled solutions to power the platform, which should allow health-care professionals to manage digital-clinical imaging. The platform will provide access to diagnostic imaging analysis applications, protocol management tools and AI algorithms, giving physicians the potential to increase efficiency and reduce errors, the German chemical and pharmaceutical conglomerate said.

Blackford Analysis will provide the underlying technology for Bayer to develop its digital solutions, it added.


Write to Cecilia Butini at


(END) Dow Jones Newswires

December 01, 2020 10:13 ET (15:13 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.